9.61

1.59% 0.15

After Hours: 9.42 -0.19 -1.98%

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $9.61, with a volume of 512.75K. It is up +1.59% in the last 24 hours and up +9.33% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$9.46

Open:

$9.49

24h Volume:

512.75K

Relative Volume:

0.62

Market Cap:

$569.10M

Revenue:

$1.08B

Net Income/Loss:

$139.50M

P/E Ratio:

4.0523

EPS:

2.3715

Net Cash Flow:

$205.80M

1W Performance:

+8.22%

1M Performance:

+9.33%

6M Performance:

-30.76%

1Y Performance:

-19.31%

1-Day Range:

$9.38

$9.69

1-Week Range:

$8.60

$9.725

52-Week Range:

$8.47

$15.55

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1112)

Industry

Medical Instruments & Supplies (57)

Phone

(862) 401-0000

Address

1209 ORANGE STREET, WILMINGTON

Employee

1,850

Twitter

Next Earnings Date

2025-11-25

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	9.61	560.22M	1.08B	139.50M	205.80M	2.3715
ISRG Intuitive Surgical Inc	468.36	165.94B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.52	44.30B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	80.73	38.96B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.93	38.69B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	228.80	33.61B	5.40B	1.49B	1.78B	10.12

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Initiated	Mizuho	Neutral
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

Apr 15, 2026

(EMBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 15, 2026

How The Embecta (EMBC) Investment Story Is Shifting As Fair Value And Expectations Reset - Yahoo Finance

Apr 15, 2026

Apr 14, 2026

Embecta Corp stock (US29082K1051): Why does its diabetes focus matter more for U.S. investors now? - AD HOC NEWS

Apr 14, 2026

Apr 09, 2026

Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88? - Yahoo Finance

Apr 09, 2026

Embecta Corp stock: What investors need to know about its diabetes focus now - AD HOC NEWS

Apr 09, 2026